The benefits of glucose-insulin-potassium for acute myocardial infarction (and some concerns).
Apstein
Carl S
CS
D015906:Angioplasty, Balloon, Coronary; D003131:Combined Modality Therapy; D048909:Diabetes Complications; D005440:Fluid Therapy / Q000379:methods*; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications / Q000378:metabolism / Q000401:mortality / Q000628:therapy*; D009426:Netherlands / Q000453:epidemiology; D011188:Potassium / Q000627:therapeutic use*; D016019:Survival Analysis; D013781:Texas / Q000453:epidemiology; D013997:Time Factors; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D007328:Insulin; D005947:Glucose; D011188:Potassium